Allegro Ophthalmics Completes Enrollment in DEL MAR Phase 2b, Stage 2 Clinical Trial of Luminate® for the Treatment of Diabetic Macular Edema
SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--Allegro Ophthalmics completes enrollment in stage 2 of its DEL MAR trial evaluating the safety and efficacy of Luminate in combination and as an adjunctive therapy with anti-VEGFs in patients with DME